Dergiler / European journal of geriatrics and gerontology (Online) / 2020 / Cilt: 2 - Sayı: 2

The Frequency of Sarcopenia and Associated Factors in Older Patients with Rheumatoid Arthritis

Sayfa
41–45
Yayın Tarihi
2022-10-12
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Overall, sarcopenia and its consequences should be considered for the geriatric population.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Rheumatoid arthritis (RA) is a progressive, systemic, and autoimmune disease.
📊
Temel Bulgular & Veri:On the other hand, sarcopenia is a Geriatric syndrome characterized by a decrease in muscle mass and strength.
💡
Sonuç & Katkı:Overall, sarcopenia and its consequences should be considered for the geriatric population.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Objective: Rheumatoid arthritis (RA) is a progressive, systemic, and autoimmune disease. On the other hand, sarcopenia is a Geriatric syndrome characterized by a decrease in muscle mass and strength. Identifying and detecting factors associated with sarcopenia is critical for screening and treatment of older patients with RA.Materials and Methods: First off, Muscle Mass index and Free Fat Mass index in 30 young, healthy males and 30 young, healthy females were assessed using a bioimpedance analyzer to find cut-off values for sarcopenia diagnosis. Then, 100 RA patients over 65 years were recruited for the same test, and patients with a value 2 standard deviation below the calculated cut-off levels were diagnosed as having low muscle mass. Patients who had low muscle mass plus (low handgrip strength or low gait speed) were diagnosed as sarcopenic. In addition, the sample was divided into two groups as sarcopenic and non-sarcopenic. Demographic characteristics, medication history, bioimpedance value, daily life activities, frailtyrate, malnutrition rate, hemoglobin level, 25-OH vitamin D level, glomerular filtration rate, rheumatoid factor, anti-cyclic citrullinated peptide seropositivity, and erythrocyte sedimentation rates (ESR) and C-reactive protein (CRP) level were compared between the groups.Results: The sarcopenic group was older than the other group. Nobody was found to use any biological agent in the sarcopenic group, but 8 nonsarcopenic patients had used biological agents previously. Malnutrition and frailty rate and level of dependence in activities of daily living were higher in the sarcopenic group than in the non-sarcopenic group. Not with standing, both groups had similar Disease Activity score-28; ESR and CRP level were higher in the sarcopenic group. Conclusion: The prevalence of sarcopenia rises with aging, malnutrition, and frailty. Accompanying with an autoimmune disease like RA, sarcopenia causes disabilities, dependence, and mortality at higher rates. Overall, sarcopenia and its consequences should be considered for the geriatric population.

🔖

Bu Makaleye Atıf Yap

Varlı, M., Aras, S., Karahan, İ., Cengiz, Ö. K., Çınar, E., Atlı, T. (2022). The Frequency of Sarcopenia and Associated Factors in Older Patients with Rheumatoid Arthritis. European journal of geriatrics and gerontology (Online), Cilt: 2 - Sayı: 2, 41–45. https://ajindex.com/articles/511230

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (9)

  1. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, Boirie Y, Cederholm T, Landi F, Martin FC, Michel JP, Rolland Y, Schneider SM, Topinková E, Vandewoude M, Zamboni M; European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing 2010;39:412-423
  2. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, Cooper C, Landi F, Rolland Y, Sayer AA, Schneider SM, Sieber CC, Topinkova E, Vandewoude M, Visser M, Zamboni M; Writing Group for the European Working Group on Sarcopenia in Older People 2 (EWGSOP2), and the Extended Group for EWGSOP2. Sarcopenia: Revised European consensus on definition and diagnosis. Age Ageing 2019;48:16-31
  3. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, Abellan van Kan G, Andrieu S, Bauer J, Breuille D, Cederholm T, Chandler J, De Meynard C, Donini L, Harris T, Kannt A, Keime Guibert F, Onder G, Papanicolaou D, Rolland Y, Rooks D, Sieber C, Souhami E, Verlaan S, Zamboni M. Sarcopenia: An Undiagnosed Condition in Older Adults. Current Consensus Definition: Prevalence, Etiology, and Consequences. International Working Group on Sarcopenia. J Am Med Dir Assoc 2011;12:249-256
  4. Hanaoka BY, Ithurburn MP, Rigsbee CA, Bridges SL, Moellering DR, Gower B, Bamman M. Chronic Inflammation in Rheumatoid Arthritis and Mediators of Skeletal Muscle Pathology and Physical Impairment: A Review. Arthritis Care Res 2019;71:173-177
  5. Elkan AC, Engvall IL, Cederholm T, Hafström I. Rheumatoid cachexia, central obesity and malnutrition in patients with low-active rheumatoid arthritis: Feasibility of anthropometry, Mini Nutritional Assessment and body composition techniques. Eur J Nutr 2009;48:315-322. 6. da Costa JP, Vitorino R, Silva GM, Vogel C, Duarte AC, Rocha-Santos T. A synopsis on aging-Theories, mechanisms and future prospects. Ageing Res Rev 2016;29:90-112
  6. Dello SAWG, Lodewick TM, Van Dam RM, Reisinger KW, Van Den Broek MAJ, Von Meyenfeldt MF, Bemelmans MH, Olde Damink SW, Dejong CH. Sarcopenia negatively affects preoperative total functional liver volume in patients undergoing liver resection. HPB 2013;15:165-169
  7. Shankar P. Frailty, muscle atrophy, and sarcopenia. J Mahatma Gandhi Inst Med Sci 2013;18:91
  8. Mühlberg W, Sieber C. Sarcopenia and frailty in geriatric patients: Implications for training and prevention. Zeitschrift fur Gerontologie und Geriatrie 2004;37:2-8
  9. Ethgen O,